[Federal Register Volume 74, Number 96 (Wednesday, May 20, 2009)]
[Notices]
[Pages 23720-23721]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-11675]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Nominations to the Advisory Committee on Blood Safety and
Availability
AGENCY: Department of Health and Human Services, Office of the
Secretary.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Office of Public Health and Science (OPHS) is seeking
nominations of qualified individuals to be considered for appointment
as members of the Advisory Committee on Blood Safety and Availability
(ACBSA). ACBSA is a Federal advisory committee in the Department of
Health and Human Services. Management support for the activities of
this Committee is the responsibility of the OPHS.
The qualified individuals will be nominated to the Secretary of
Health and Human Services for consideration of appointment as members
of the ACBSA. Members of the Committee, including the Chair, are
appointed by the Secretary. Members are invited to serve on the
Committee for up to four-year terms.
DATES: All nominations must be received no later than 4 p.m. EDT on
June 30, 2009, at the address listed below.
ADDRESSES: All nominations should be mailed or delivered to Dr. Jerry
Holmberg, Executive Secretary, Advisory Committee on Blood Safety and
Availability, Office of Public Health and Science, Department of Health
and Human Services, 1101 Wootton Parkway, Suite 250, Rockville, MD
20852. Telephone: (240) 453-8803.
FOR FURTHER INFORMATION CONTACT: Dr. Jerry Holmberg, Executive
Secretary, Advisory Committee on Blood Safety and Availability, Office
of Public Health and Science, Department of Health and Human Services,
1101 Wootton Parkway, Suite 250, Rockville, MD 20852. Telephone: (240)
453-8803.
A copy of the Committee charter and roster of the current
membership can be obtained by contacting Dr. Holmberg or by accessing
the ACBSA Web site at http://www.hhs.gov/bloodsafety. http://www.hhs.gov/bloodsafety.
SUPPLEMENTARY INFORMATION: The Advisory Committee on Blood Safety and
Availability advises the Secretary and the Assistant Secretary for
Health. The Committee provides advice on a range of policy issues to
include: (1) Definition of public health parameters around safety and
availability of the blood and blood products, (2) broad public health,
ethical, and legal issues related to transfusion and transplantation
safety, and (3) the implications for safety and availability of various
economic factors affecting product cost and supply.
The ACBSA consists of 20 voting members. The Committee is composed
of 14 public members, including the Chair, and six (6) representative
members. The public members are selected from State and local
organizations, advocacy groups, provider organizations, academic
researchers, ethicists, private physicians, scientists, consumer
advocates, legal organizations, and from among communities of persons
who are frequent recipients of blood or blood products. There are six
(6) individuals designated to serve as official representative members
of the blood and blood products industry or professional organizations.
These representative members shall be from AABB (formerly the American
Association of Blood Banks), Plasma Protein Therapeutic Association
(PPTA), one of the two major distributors of blood on a rotating basis,
a trade organization or manufacturer of blood, plasma, or other tissue
test kits or equipment, and a major hospital organization that
purchases blood and blood products.
All ACBSA members are authorized to receive the prescribed per diem
allowance and reimbursement for travel expenses that are incurred to
attend meetings and conduct Committee-related business, in accordance
with Standard Government Travel Regulations. Individuals who are
appointed to serve as public members are authorized also to receive a
stipend for attending Committee meetings and to carry out other
Committee-related business. Individuals who are appointed to serve as
representative members for a particular interest group or industry are
not authorized to receive a stipend for the performance of these
duties.
This announcement is to solicit nominations of qualified candidates
to fill positions on the ACBSA that are scheduled to be vacated in the
public member category. The positions are scheduled to be vacated on
March 1, 2010.
Nominations
Persons nominated for appointment as members of the ACBSA should be
among authorities knowledgeable in blood banking, transfusion medicine,
plasma therapies, transfusion and transplantation safety, bioethics,
and/or related disciplines. Nominations should be typewritten. The
following information should be included in the package of material
submitted for each individual being nominated for consideration of
appointment: (a) The name, return address, daytime telephone number and
affiliation(s) of the individual being nominated, the basis for the
individual's nomination, the category for which the individual is being
nominated, and a statement bearing an original signature of the
nominated individual that, if appointed, he or she is willing to serve
as a member of the Committee; (b) the name, return address, and daytime
telephone number at which the nominator may be contacted.
Organizational nominators must identify a principal contact person in
addition to the contact; and (c) a copy of a current curriculum vitae
or resume for the nominated individual.
Individuals can nominate themselves for consideration of
appointment to the Committee. All nominations must include the required
information.
[[Page 23721]]
Incomplete nominations will not be processed for consideration. The
letter from the nominator and certification of the nominated individual
must bear original signatures; reproduced copies of these signatures
are not acceptable.
The Department of Health and Human Services is committed to
ensuring that women, minority groups, and physically challenged
individuals are adequately represented on the Committee. Nominations of
qualified candidates from these categories are encouraged. The
Department also seeks to have geographic diversity reflected in the
composition of the Committee.
The Standards of Ethical Conduct for Employees of the Executive
Branch are applicable to individuals who are appointed as public
members of Federal advisory committees. Individuals appointed to serve
as public members of Federal advisory committees are classified as
special Government employees (SGEs). SGEs are Government employees for
purposes of the conflict of interest laws. Therefore, individuals
appointed to serve as public members of the ACBSA are subject to an
ethics review. The ethics review is conducted to determine if the
individual has any interests and/or activities in the private sector
that may conflict with performance of their official duties as a member
of the Committee. Individuals appointed to serve as public members of
the Committee will be required to disclose information regarding
financial holdings, consultancies, and research grants and/or
contracts.
Dated: May 14, 2009.
Jerry A. Holmberg,
Executive Secretary, Advisory Committee on Blood Safety and
Availability.
[FR Doc. E9-11675 Filed 5-19-09; 8:45 am]
BILLING CODE 4150-41-P